CRBN and Miyoshi myopathy: To determine the epigenetic mechanisms, we performed MSP, which would evaluate the methylation pattern of CpG islands in the CRBN promoter region upon exposure to PPAR agonists in MM cell lines, including the lenalidomide-sensitive and -resistant MM cell lines.